Navigation Links
Potential hemlock hybrids tolerant to invasive hemlock woolly adelgid
Date:11/10/2010

to be most tolerant to HWA.

Details of the scientists' studies have been published in the Journal of Economic Entomology, the Journal of Arboriculture and the Journal of the American Society for Horticultural Science.

The hybrids are appealing not only due to their tolerance, but because they have good vigor and shape. Still, the researchers have several years of testing to complete before they can release these hybrids.


'/>"/>

Contact: Stephanie Yao
stephanie.yao@ars.usda.gov
301-504-1619
United States Department of Agriculture -- Research, Education and Economics
Source:Eurekalert

Page: 1 2

Related biology news :

1. Engineered plants make potential precursor to raw material for plastics
2. UCLA researchers discover a potential target for therapy for patients with a deadly prostate cancer
3. University of Illinois researchers discover potential new virus in switchgrass
4. Grasses have potential as alternate ethanol crop, Illinois study finds
5. Researchers report advances vs. preeclampsia, including potential prediction
6. Faster CARS, less damage: NIST chemical microscopy shows potential for cell diagnostics
7. Novocure reports data showing TTF therapy in combination with chemotherapy has the potential to increase overall survival for patients with advanced non-small cell lung cancer
8. Brown licenses potential muscular dystrophy treatment to Tivorsan Pharmaceuticals
9. Stem cell research: What progress has been made, what is its potential?
10. Research heralds potential for early diagnosis of degenerative brain disorders
11. Potential HIV drug keeps virus out of cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... for DISTRIBUTED VOICE DIRECTED PAYMENT METHOD AND ... new groundbreaking payment method. Payment accounts may be selected ... be accessed if both the speech (the word associated ...
(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
(Date:2/11/2015)... DALLAS , February 11, 2015 /PRNewswire/ ... market research report "Access Control Market by Product ... (Commercial, Residential, Military and Defense, Government, Industrial, Healthcare, ... , published by MarketsandMarkets, the Access Control ... by 2020, growing at a CAGR of ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3ACT Genomics Raises $8 Million in its First Private Funding Round 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... What do blinking fireflies, the cellular power plants that are ... have in common? At first glance, not a lot; but, ... the tapestry of knowledge for those trying to patch the ... the coming days, as part of the Experimental Biology 2011 ...
... WASHINGTON, April 7, 2011 -- Dozens of researchers in ... in the biochemical battle of the bulge as part of ... The three-day program on obesity, sponsored by the American Society ... the work of scientists from all over the world who ...
... E. Johnson, a distinguished professor at the Texas A&M ... to give the Fritz Lipmann Lectureship at the American ... Washington, D.C. Johnson will give his talk, "Membrane Protein ... C of the Walter E. Washington Convention Center, where ...
Cached Biology News:Hot topics in chemical biology and drug development at EB2011 2Hot topics in chemical biology and drug development at EB2011 3Hot topics in chemical biology and drug development at EB2011 4Hot topics in chemical biology and drug development at EB2011 5What's coming next in the biochemical battle of the bulge? 2Texas researcher Arthur E. Johnson to give prestigious ASBMB-Lipmann Lectureship 2
(Date:3/4/2015)... -- The UPMC Center for Health Security today announced ... Leaders in Biosecurity Initiative (ELBI). As part of our ... biosecurity, UPMC has selected 28 US and international emerging ... including biological science, medicine, policy, the military, think tanks ... vision and support of the Defense Threat Reduction Agency ...
(Date:3/4/2015)... 4, 2015 /CNW/ - Resverlogix Corp. (TSX:RVX) (the ... a collaborative research program with Emerald Logic, ... Collective Evolution Technology (FACET), Emerald Logic analyzed ... obtained from each of 798 patients who ... trials ASSERT, SUSTAIN and ASSURE. The objective ...
(Date:3/4/2015)... SEOUL, South Korea , March 4, 2015 /PRNewswire/ ... based biopesticide company, in August of last year. As ... with Kyung Bon Koo continuing his role ... Selakovic , President of Vegalab S.A., will work alongside ... Photo - http://photos.prnewswire.com/prnh/20150303/179218 ...
(Date:3/3/2015)... 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, ... molecular diagnostics that target the underlying mechanisms of cancer, ... period ended December 31, 2014. Effective July ... from May 31 to December 31. As a result ... are for the quarter and the seven months ended ...
Breaking Biology Technology:UPMC Center for Health Security Announces 2015 Emerging Leaders in Biosecurity 2UPMC Center for Health Security Announces 2015 Emerging Leaders in Biosecurity 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12
... Phytomedics Inc., a clinical,stage biopharmaceutical company developing ... it will present at the,Wachovia 2008 Healthcare Conference ... p.m. ET., Among the topics of the ... and business developments, including Phase III development,activities related ...
... (OTC:,NNLX - News) a nano-biotechnology company is pleased ... development at a,Welch,s juice plant in Pennsylvania has ... Allegheny Front" - Environmental Radio for Western,Pennsylvania". The ... aired,January 23rd on WYEP- FM, a listener-supported public ...
... Corporation today,announces that Mr. Mark Ostrowski has joined ... Mr. Ostrowski will be responsible for overseeing,the growth ... and,marketing efforts in support of the substantial momentum ... has more than 17 years experience in biotechnology ...
Cached Biology Technology:NanoLogix's Hydrogen-From-Waste Technology at Welch's Foods Featured on Environmental Radio Program 2Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing 2
... Adept CE 4100 high pressure pump ... precision, with software drive compensation, reducing pulsing ... are selectable in 0.001mL steps. , The ... and bio-compatible., Pumps may be programmed from ...
High affinity antibodies recognizes HSP70 protein from human cardiac tissue. Could be used for Westerb blotting application, ELISA....
Recommended for use as a cell culture substratum at 0.1-0.2 mg/cm 2 or 5-10 μl/cm 2 . Optimal concentration depends on cell type as well as the application or research objectives. Type B...
Monoclonal antibodies conjugated with rhodamine...
Biology Products: